Turn Therapeutics Inc. 8-K

What Happened

• On February 9, 2026, Turn Therapeutics, Inc. (TTRX) filed a Form 8-K under Item 7.01 (Regulation FD Disclosure) announcing that it issued a press release about upcoming presentations at Healthcare conferences and posted an updated investor presentation to its website. The press release and the investor presentation were furnished as Exhibits 99.1 and 99.2 to the filing.

Key Details

• Filing date: February 9, 2026 (Form 8-K).
• Press release announced upcoming presentations at Healthcare conferences (Exhibit 99.1).
• Updated investor presentation posted to the company website (Exhibit 99.2).
• The filing includes the interactive cover page XBRL file (Exhibit 104).

Why It Matters

• These Reg FD disclosures make the company’s conference plans and its latest investor materials publicly available, giving investors a chance to review any recent program, pipeline, or corporate updates the company plans to present. Investors should read the press release and the updated investor presentation (linked in the exhibits or on TTRX’s investor site) for specifics on presentation timing and content.